Buzz Pocket

Wednesday, February 17, 2021

Growth Outlook: Cancer Stem Cells Market Top Scenario, SWOT Analysis, Business Overview & Forecast 2027

according to a study, cancer stem cells market by research dive, the global market will surpass $1,722.7 million by 2026. rising number of cancer patients, coupled with the latest advancements in cancer stem cells will upsurge the global market by the year 2026.

Rising tension of cancer all over the world is one of the significant factor which drives the growth of cancer stem cells market. According to the World Health Organization (WHO), one out of six deaths are occurs due to cancers such as breast cancer, lungs cancer and others. The causes for the growing cases of cancer patients include urban air pollution, sexually transmitted HPV infection, alcohol consumption, poor intake of fruit and vegetables. Moreover, late-stage presentation and inaccessible diagnosis are the common factor which increases risk of cancer. On the other hand, stem cell research has capability to manufacture different types of medicines for diseases along with finding drugs that can be used for treatment of cancer. However, issues such as expensive stem cell therapy treatments & strict international rules and are hampering the global cancer stem cells market growth. Such therapy utilizes living cells to treat disease coupled with processes like collecting, altering, storing and applying to technology. Thus, the cost of stem cell therapy ranges between $5,000 to $8,000 per stem cell treatment also it can be around $25,000 or more than that.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/32

Researchers of Tel Aviv University introduced newly advanced biosensor which can target leukemic stem cells. They are more focusing on decreasing the rate of relapse in blood cancer by targeting most malignant leukemic stem cells. Such latest technological advancements anticipated to drive the growth of market. Stem cell research is the rapidly growing medical practice in Turkey. Therefore, this country is now recognized as ‘rising star of Europe in stem cell’. Turkish hospitality and friendliness is well deserved along with ‘high quality, low cost stem cell treatment’, modern laboratory equipment creating enormous opportunities for the investors of stem cells.

• Segmentation Growth Definition of Cancer Stem Cells Market:

Breast cancer market will surpass $295.0 million in the year 2026, and is anticipated to rise at 10.4% CAGR during the estimate period. The cancer stem cells market for bladder is anticipated to increase at 11.2% CAGR, and will surpass $275.8 million by 2026, rising from $117.9 million in 2018.

Global market for stem cell based cancer therapy was $440.3 million by end of 2018 and is anticipated to grow at 9.3% CAGR. This is majorly due to the rising advancements in stem cell therapy of Asia-Pacific and Europe region.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/32

• Regional Investment Opportunities:

North America cancer stem cell market is generated revenue of $365.64 million by end of 2018 and is anticipated to rise at 10% CAGR during the analyzed period. Asia-Pacific market registered a growth rate of 11.2% during the forecast period. This market will surpass $367.68 million by 2026, growing from $157.26 million in 2018. China, India, and Japan are the key contributors to the growth of regional market.

• Key players in cancer stem cells market and their strategies:

Some of the major players in the global cancer stem cells market are AdnaGen GmbH, Advanced Cell Diagnostics, Inc., AVIVA Biosciences Corporation, Celula, Inc., Epic Sciences, Inc., Fluxion Biosciences, Inc., Rarecells USA, Inc. and Silicon Biosystems, S.p.A. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development etc. For instance, in January 2019, Fluxion Biosciences launched custom liquid biopsy NGS (Next Generation Sequencing) panel development. In liquid biopsy, NGS has been applied to sequencing of circulating tumor DNA. This technology has led to noteworthy reduction in the cost of sequencing coupled with improved accuracy.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Top Scenario: Organ Care System for Heart Market by Key Vendors, Challenges and Opportunities 2027

according to a study, organ care system market for heart by research dive, the market was accounted for $11.0 million in 2018, is anticipated to reach $37.2 million by the end of 2026, at a cagr of 16.5%.

The global organ care system market for heart is majorly driven by increasing the number of patients suffering from cardiovascular diseases. The common problem for cardiovascular disease is due to heart failure. According to the World Health Organization (WHO), 17.9 million people around the world are suffering from cardiovascular diseases every year, and 37% of deaths are occurring. In such cases, heart transplantation is the only solution, which will be a major driving factor for this market. In addition to this, alcohol consumption and tobacco usage are increasing regularly among people, and they leads to heart strokes and heart attacks. This will also provide a significant boost to the organ care system heart market size during the projected period.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/35

Treatment cost for heart transplantation, coupled with the shortage of organ availability for conducting transplantation will hinder the organ care system market for heart. This is creating a huge wait time for the new receivers for heart transplantation, and this will also act as a significant restraint for this market to grow. Various governing bodies are taking initiatives in order to create awareness among the people about organ donation, for example, the National Organ Transplant Program in India and a nonprofit organization in the U.S. Donate Life America are significantly creating awareness among the people about the organ donation and their benefits.

The OCS market for heart is categorized into two types, based on mode of handling, trolley and portable type. Portable organ care systems’ segment is expected a robust growth in the coming years and projected to reach $4.7 million by 2026, growing at a rate of 18.0%, owing to its portability. Trolley organ care system is estimated to reach $6.3 million and at 15.3% CAGR.

Asia-Pacific organ care system market for heart will witness substantial growth during the forecast time period, and is projected to account for $4.6 million by 2026, at a CAGR of 12.0%. This is due to the growing initiatives from government in the developing countries of this region, such as the execution of organ transplantation and conducting organ donation awareness programs in Asia-Pacific countries. Moreover, OCS heart market in Europe is expected to account for $6.5 million, at a growth rate of 11.0% by the end of 2026. This is due to growing the market participants.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/35

• North American Organ Care System Market:

North America dominated the global market of Organ Care System Market and registered for $5.2 million in 2018, is estimated to grow in the coming years, and projected to reach $22.2 million by 2026, at 22.0% CAGR. This is owing to the majority of the key participants in this region.

• Advancements and Key Players in organ care system market for Hearth:

Paragonix Technologies Inc., and TransMedics Inc., are the major key players in the global organ care system market. The key participants are concentrating on advancements in new technology, upgradation of available technologies and introducing new products. In March 2019, Paragonix Technologies demonstrated “Paragonix SherpaPak Cardiac Transport System” at the International Society for Heart and Lung Transplantation (ISHLT), 2019 annual meeting. This is an organ storage system and organ can be stored up to 4 hrs.

Contact Us:

Industry Verticals: Chromatography Systems Market by Key Driver, Challenges and Opportunities 2027

the global chromatography systems market has registered for $9739.4 million in 2018, according to a new report published by research dive. the market is anticipated to reach $16014.9 million by 2026 and at a cagr of 6.6% over forecast period.

The global Market is mainly driven by the hospital & research industry, due to wide range of usage in R&D activities, separation of complex mixtures and cancer cells identification in human body. In food industry the chromatography technique is utilized for separation of organic compounds, vitamins, amino acids and contaminants in the food product, these will enhance the growth of the chromatography market. Increasing the usage of chromatography technique in forensic labs and research laboratories to identify if a dead person has consumed alcohol or drugs previous to death, in addition to identify if the person was poisoned. Additionally, the chromatography system has wide range of applications such as air quality monitoring. In chemical industry air monitoring is used to identify the purity of chemicals and examining the chemical compounds that will enhance the Chromatography Systems Market growth. The price of the device and availability of alternative techniques will restrict the growth of chromatic system market. Lack of skilled labor is the major factor hindering the chromatography systems market growth.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/37

Chromatography system in global market is classified on the basis of type and end-use. As per the type, the global chromatography is divided into gas chromatography, liquid chromatography and others. Gas Chromatography Systems Market is generated majority of the revenue in 2018 and it is expected to reach $7145.1 million and at a CAGR of 7.1%, over forecast timeframe. This is due to gas chromatography is widely used in petrochemical industry and research laboratories. Beside gas chromatography, the liquid chromatography market is estimated significant growth over forecast period, at a 7.5 %CAGR.

On the basis of end-use, hospital & research industry is dominated the chromatography system in global market in 2018, is anticipated to produce $5983.1 million by 2026, and at a 7.0% CAGR, owing to extensively use as diagnostic tool in hospital & research industry. Additionally, pharmaceutical segment will experience significant growth and projected to account for $5651.4 million by 2026, at a CAGR of 7.3%, owing to liquid chromatography is the essential technique in pharmaceutical industry for development and purification of medicine compounds and analysis of contaminants in drugs.

• Asia Pacific Chromatography Systems Market

Asia Pacific will experience significant growth and expected to reach $3283.9 million by 2026, and at a CAGR of 7.5%. This is owing to increase in the research and development activities in pharmaceutical and biomedical industry to produce new products. Along with Asia-Pacific, Europe Chromatography Systems Market is anticipated to experience vigorous growth and is projected to reach $5176.2 million by the end of 2026, at a CAGR of 7.1%. This is due to investments done by the chemical and pharmaceutical industries for merger & acquisitions and geographically expansions. Chromatography is strong analytic technique in pharmaceutical industry.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/37

• North America Chromatography Systems Market

The chromatography market for North America region held highest value, and accounted for $3521.5 million in 2018, and is expected to account for $5960.6 million, at a CAGR of 6.8% during forecast timeframe. This is due to rising the usage of chromatography technique in pharmaceutical & biotechnology industry, government investments on forensic testing and biomedical application

• Top 10 Key Players in Chromatography Systems Market includes-

1. Waters Corporation
2. JASCO Inc.
3. Novasep Holding
4. Agilent Technologies Inc.
5. Perkin Elmer Inc.
6. Quadrex Corporation
7. GE Healthcare
8. Bio-Rad Laboratories Inc.
9. Thermo Fisher Scientific
10. GL Sciences Inc.

These companies are adopting new strategies such as R&D investments, new product launches and mergers and acquisitions to gain highest market share in the overall industry. The Agilent Technologies is launched new instrument “Agilent 8860 GC system” for Indian market in February 2019, which is the upgradation of routine GC analysis.

Contact Us:

Development Trends: Therapeutic Obstructive Sleep Apnea Device Market by Top Key Players, Applications and Forecast to 2020-2027

global market was valued at $ 4,661.6 million in 2018 and is expected to reach of $ 9,561.3 million by 2026, growing at a cagr of 9.6% over the forecast period.

Obstructive sleep apnea is caused due to the blockage of the airways. This happens during sleep when the tongue folds with the soft palate and stops the air to pass on against the throat. It is being estimated that most of the mid age population tends to experience obstructive sleep apnea more than 5 times in half an hour.

Increasing number of cases in the sleep apnea is expected to drive the market for the therapeutic obstructive sleep apnea devices. It has been estimated that, around 80% of the patient who are suffering from obstructive sleep apnea are not being treated. The ratio between the total number of patients facing the obstructive sleep apnea and the patient who is being diagnosed is very minimal, so rising awareness among the patient can lead to the growth of the therapeutic obstructive sleep apnea market. Lack of awareness regarding the effects caused due to the obstructive sleep apnea such as, high blood pressure, diabetes, obesity and sometime the death of the patient may occur due to negligence and unawareness. Government initiative to raise the awareness among the people and the advanced technologies expected to give a boost to the overall obstructive sleep apnea therapeutic devices market.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/39

The main reason for dissension of therapeutic obstructive sleep apnea devices is due to the lack of acceptance from the patients, this is mainly due to the discomfort and anxiety caused by the mask. The cost of therapeutic obstructive sleep apnea devices market is very high as compared to the other sleep apnea disease. The cost is the main constraint for the increase of the therapeutic obstructive sleep apnea devices market.

Depending on the type the positive airway pressure segment held the largest market size in 2018 for $2,187.8 million and is expected to reach $4,542.3 million by 2026, at a CAGR of 9.7%. Positive airways reduce the sleep apnea occurrence and protect the airways from closing. The oral application is estimated to grow at 9.5% CAGR by generating revenue by $1,768.2 million by 2026. It is expected to offer patient with greater satisfaction. Oral applications are portable, flexible and easy to use, so American Academy of Sleep Medicine (AASM) suggested to wear oral application with severe obstructive sleep apnea, who cannot wear and use positive airway pressure.

Due to the rising number of hospitals and growing investment in healthcare the hospitals and sleep laboratories segment is anticipated to drive the market over the forecast period. Hospitals and sleep laboratories segment accounted for $2,569.3 million in 2018 and is expected to rise at a CAGR of 9.4% in the forecast period.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/39

North America holds the largest market share for the therapeutic obstructive sleep apnea devices market. This region registered 10.2% CAGR and is anticipated to generate a revenue of $3,970.7 million by 2026. The Asia-Pacific is the largest growing market for the therapeutic obstructive sleep apnea devices as most of the Asian countries are not developed in the medical facilities and are unaware of the therapeutic obstructive sleep apnea devices. It is projected that the region sleep apnea devices market is expected to grow at $1,777.7 million by 2026 at a CAGR of 9.0%.

The major key players in the therapeutic obstructive sleep apnea devices market are Invacare Corporation GE Healthcare, Compumedics Limited, BMC Medical Co., Fisher & Paykel Healthcare, Cadwell Laboratories Inc., Ltd, Braebon Medical Corporation, Becton Dickinson (CareFusion Corporation), Curative Medical Inc., ImThera Medical, Inc.

Contact Us:

Future Growth: Breast Implant Market by Key Driver, Challenges and Opportunities 2027

breast implant market size will exceed $4.9 billion by 2026, growing at a cagr of over 10.3% from 2019 to 2026; according to a new research study by research dive.

An increase in the number of breast augmentation processes, along with the rise in breast cancer incidences across the world will significantly drive the global breast implant market size over the forecast period. The breast augmentation processes enable women to improve their breast size, and also to improve their hip contour balance. These are also called as reconstruction procedures, which help to restore the breasts’ size to near normal size. They also help in improving the appearance of the breasts. Rapid growth in these procedures will significantly spur the global breast implant market growth during the projected timeline.

Rapid growth in the incidences of breast cancer across the world will boost the growth of breast implant market growth in the coming years. As a result of this, the majority women are preferring mastectomy procedures during their breast cancer treatment.

However, the high cost of implantation procedures, coupled with the rising implications post-surgeries will impede the breast implant market growth.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/41

The silicone breast implant market size held the largest share in 2018 and is projected to grow at a CAGR of over 10.2% over the projected timeframe. The dominant market size is expected throughout the forecast period, owing to the product’s capability to look natural. Some of the other benefits such as reduced wrinkling will further provide a significant boost to product adoption.

The breast implant market for reconstruction procedure will increase at a CAGR of more than 10.7% during the projected period. This is majorly due to the increasing incidences of breast cancer, and also to avoid them. An increase in awareness about reconstruction surgery to overcome the cancer incidences has resulted in significant growth in procedure adoption.

The majority of the patients are preferring clinics as their place of surgery. This is majorly due to the presence of skilled professionals, coupled with the less cost associated with the comparison with the hospital sector. Breast implant procedures in clinics will grow at a CAGR of over 9.8% during the projected period. Expanding infrastructure in the healthcare sector in the emerging economies will further enhance the market growth. This segment will further grow on account of the availability of skilled plastic surgeons in the clinics.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/41

North America market held a significant market share in 2018 and accounted for more than 40% in 2018. An increase in the number of the female population preferring the augmentation procedures will further drive the market growth. Growth in per capita expenditure, coupled with the rise in disposable income will further serve to be one of the high impacting factors for the growth of North America breast implant market growth.

The Asia-Pacific market is projected to witness a robust growth at 11.0% CAGR during the forecast period. The rise in the number of hospitals and clinics offering plastic surgery procedures, coupled with the increase in the number of plastic surgeons in this region will enhance the regional market growth during the coming years.

Some of the prominent companies in the global breast implant market include GC Aesthetics, Allergan, Mentor Worldwide LLC, Laboratoires Arion, Groupe Sebbin, Hansbiomed Co. Ltd., Sientra Inc., Silimed, Groupe Sebbin SAS, and CEREPLAS among many others. Some of the strategies preferred by the operating companies are product development and acquisitions.

Contact Us:

Driving Innovation: Autotransfusion Devices Market - Future Growth, & Forecast to 2027

according to a recent report published by research dive, titled, “autotransfusion devices market by type, and application: global opportunity analysis and industry forecast, 2018-2027,” the global autotransfusion devices market size was $1,121.5 million in 2018, and is anticipated to reach $1,939.7 million by 2027, at 6.5% cagr from 2019 to 2027.

The North America regional market dominates the global market, followed by Europe, Asia-Pacific, and LAMEA. U.S. dominated the global autotransfusion devices market share in 2018, and is expected to grow at a significant rate during the forecast period.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of autotransfusion: Blood can be autologously “pre-donated” (termed so despite “donation” not typically referring to giving to one’s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device (such as a Cell Saver or CATS). The latter form of autotransfusion is utilized in surgeries where there is expected a large volume blood loss – e.g. aneurysm, total joint replacement, and spinal surgeries. The device used for autotransfusion is called autotransfusion devices. Presently, many surgeons utilize autotransfusion innovatively such as with a cell processing step which not only is efficient and less time consuming but also enables the patient to have safe blood transfusion. Moreover changing lifestyles coupled with the increasing obesity amongst the masses has resulted in increased chances of having cardiac diseases which has prompted the growth of Autotransfusion devices.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/49

High occurrence of cardiac diseases leads to the huge demand of auto-transfusion device across the world. Furthermore, absence of any risk of transfusion or transmitted infections is boosting the growth for autotransfusion devices globally. On the contrary, inability to separate contaminants from blood is expected to be a major restraint for autotransfusion devices market. On the other hand, growing Adoption of whole body autotransfusion devices.

Off-Pump Autotransfusion devices holds the highest market share amongst the product type segment and is expected to grow with a CAGR of 6.6% during the forecast period 2019-2027. The driving factor for off-pump transfusion is the device usage ease, coupled with no blood loss feature during the transfusion process. Major trends in the off-pump transfusion is its efficacy and the fact that off-pump transfusion have much lower post-operative morbidity and mortality especially in high risk patients.

Amongst the end use segment, Hospital segment holds the largest market share and is expected to grow at CAGR of 6.6% during the forecast period. This primarily because, the hospitals have specialized departments wherein blood transfusion is required as such the autotransfusion devices are required in multiple numbers to cater to various transfusion requirements of specialized diseases in various department.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/49

North America has the highest market share for autotransfusion device globally and is expected to grow at a healthy rate of 6.4% over the forecast period. U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. As the regulatory standards regarding transfusion are quite stringent in U.S., companies are investing a lot on Research & Development for approvals of commercial sale of Autotransfusion device and therefore they are focused on quality and innovative products so as to efficiently handle the process and edge ahead of competitors, thus driving the growth of Autotransfusion device in the country.

One of the prominent players in autotransfusion devices market viz., Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, personalized and adapts to the user. The system will also provide insights and predictive diagnostics unique to the individual, with a goal of dramatically simplifying diabetes management for the patient. The recent acquisition of Nutrino Health and their expertise in nutrition data science will play a key role in the accelerated development of this breakthrough technology. Zimmer Biomet Holding, Becton Dickinson and Company, LivaNova, Plc, Teleflex Incorporated, Stryker Corporation, Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Haemonetics Corporation and Getinge AB.

Contact Us:

Industry Dynamics: Animal Parasiticides Market Revenue, Growth Rates, and Industry Challenges in 2020-2027

according to a new report published by research dive, the global animal parasiticide market forecast will be $7,082.2 million by 2026, rising from $5,096.0 million in 2018, and at 4.2% cagr.

The significant animal parasiticide market drivers; are increasing the adoption of pet animal’s and awareness about the importance of parasiticide products to prevent zoonotic diseases. Increasing knowledge among the people about livestock and livestock healthcare, rising the concerns to control of zoonotic diseases in the animals and livestock is anticipated to lead the market growth in the future time. Additionally, increasing investments to develop improved parasiticide products for veterinary healthcare and rise in the expenditure on animal healthcare are further enhancing the animal parasiticide market growth in a positive manner. Parasiticide product cost and heavy R&D investments are projected to hamper the global animal parasiticide market. Animal parasiticide market advancements and rise in the government implementations to prevent the animal and livestock health are expected to generate major opportunities for the new entrants into the market in the coming years.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/56

Ectoparasiticide type market will witness a significant growth and is estimated to generate a revenue of $1,678.5 million, at a 4.6% CAGR over projected period. The rise in the demand of ectoparasiticides type to prevent or control parasite insects in animals is anticipated to boost the market growth in the coming years. Endectocides type dominated the global animal parasiticide market, it is registered for $2,293.2 million in 2018, and is projected to account for $3,109.1 million by the end of 2026. This is due to endectocides are major veterinary parasiticide that are used for the treatment of arthropods and nematodes insects affecting animals. Additionally, increase the use of endectocides to minimize parasites diversity is expected to drive the animal parasiticide market in the projected period.

The companion animals segment is expected to experience the substantial growth, it is estimated to register of $2,323.0 million, growing at a highest rate of 4.5% in the projected time frame. This is owing to the growing requirements from pet owners and veterinary centers to prevent or treat animals from the zoonotic diseases. Additionally, rise in the animal healthcare expenditure and number of pet owners are expected to enhance the animal parasiticide market over forecast timeframe. The farm animals segment has registered the highest animal parasiticide market share of 68.0% in 2018, and is estimated to generate revenue of $4,759.3 million, growing at 4.0% CAGR over projected period. This growth is attributed to high quantity requirement of parasiticides, due to huge quantity of farm animals present across the globe.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/56

Asia-Pacific market is projected witness a noteworthy growth rate, it is projected to account for $ 1,614.8 million and at a CAGR of 4.7% in the projected time period, owing to upsurge in the adoption of animals, and increase in the product demand from the quality meat consumers across the region. Additionally, rising awareness about the importance of parasiticides to control the diseases will further drive the market growth in the coming years. North America market is accounted for the highest animal parasiticide market size of $1,885.5 million in 2018, it is estimated to register of $2,556.7 million and at a 3.9% CAGR, owing to rising interest of pet animals owning among the people.

Elanco, Boehringer Ingelheim animal Health, Ceva Santé Animale, Vetoquinol, Eli Lilly, Bayer AG Zoetis Inc., Sanofi, Merck Co., and Perrigo Company Plc, are some of the animal parasiticide market players. These manufacturers are accepting the key approaches such as product infections, collaboration and partnerships in order to rise their market size in the global animal parasiticide market. For example, in September 2019, Zoetis Inc. presented positive effectiveness of triple combination of parasiticide at American Heartworm Society Meeting, which is useful for preventing animals from heartworm disease and to control and treat of fleas, intestinal and ticks in dogs.

Contact Us:

Regional Outlook: Intrathecal Drug Delivery System Market by Key Vendors, Challenges and Opportunities 2027

according to a study of research dive, intrathecal drug delivery system market forecast shall surpass $1662 million by 2027, registering a cagr of 7.2% from 2019 to 2027.

Intrathecal drugs delivery (IDD) system plays the important role in the treatments of intractable (uncontrollable) pain. IDD system utilized for selected patients which are associated with major reduction in quality of health and that have not options of other treatment. This treatment requires highly specialized team for ensuring appropriate selection along with the safety criteria.

IDD enables therapist to formulate individualized treatment regimens which can provide improved analgesia with small doses coupled with fewer adverse effects over opioid-based therapies.

The major factors that boost the global intrathecal drug delivery system market growth are rising demand for intrathecal drug delivery system for cancer pain. In addition, surge in cost-effective cancer pain treatment using such systems are expected to boost the market growth during the forecast period. However, complications of ITDD systems hamper the growth of the intrathecal drug delivery system market.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/43

Externalized and Connected with a pump holds the highest market share amongst the product type segment and is expected to register revenue of $1,358.6 million during the forecast period 2020-2027 at a CAGR of 6.8%. Externalized and connected with a pump is used in situations wherein there’s frequent need of change of catheter such as those who are suffering from cancer. They are in trend as they are cost effective compared to fully implanted systems.

These pumps have proved to be very effective for cancer pain and have been use since the last 3-4 decades and they are still in use as fully implanted systems are still in R&D phase and are not use in major developing countries.

Amongst the Application segment, Spasticity Management for intrathecal drug delivery system market size, generating revenue of $635.1 million in 2018, and is expected to grow at CAGR of 7.1% registering revenue of $1,140.2 million by 2027. ITDD devices are mostly used for spasticity management and with advent of programmable system the spasticity can be managed by controlling the flow of drug delivery. They are majorly used in European countries like Belgium, Germany, UK and others. These systems have opportunities in the developing countries wherein the spasticity problems are more pronounced.

North America has the highest Intrathecal drug delivery system market share globally and is expected to register revenue of $695.9 million growing at a healthy rate of 7.4% over the forecast period. Due to ease usage which signifies better control and long lasting nature of the Intrathecal devices North America market has highest market share for implanted Intrathecal drug device Therefore, it is one of the significant factor for growth of Intrathecal drug devices market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/43

U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. Companies are spending heavily on research & Development activities, in order to provide innovative and effective pain management solution thereby driving the growth of Intrathecal Drug delivery systems in the country.

Prominent players in Intrathecal Drug Delivery Systems are Medtronic plc is one of the potential manufacturers of programmable intrathecal drug Delivery Systems has successfully launched the Medtronic SynchroMed II (drug infusion pump), which is utilized to deliver drug into a patient’s body. The pump is used together with a catheter to deliver a specific drug to the patient’s spinal fluid. Other major players include Flownix Medical Inc, Teleflex Incorporated, DePay Synthes, Tricumed Medizintechnik GmbH, Smiths Group Plc, Summit Medical Group, B Braun Melsungen AG, Becton, Dickinson & Company and Fresenius Medical Care AG & Co. KGaA.

Contact Us:

Qualitative Analysis: Medical Marijuana Market - Future Growth, Verticals, Segmentation & Forecast to 2027

as per study of research dive, medical marijuana (cannabis) market forecast revenue of $36,205.4 million in the year 2026 growing at cagr of 28.7%.

Marijuana is more safe and has less severe side effects over other treatment options such as opioid-based treatments. It is more efficient in reducing nausea and also improving appetite among chemotherapy patients. Increasing cancer burden along with rising demand for chronic pain management & treatment is projected to drive the medical marijuana market growth. For instance, as per publication of the World Health Organization (WHO), in 2018, Cancer disease is the second leading cause of death cases, in which Lung, breast, prostate, liver, stomach and colorectal cancer are the common types of cancerous diseases. Moreover, R&D activities, Clinical trials along with commercialization of cannabis are anticipated to boost the global medical marijuana industry. However, stringent government regulation, lack of awareness in the emerging countries and absence of proper information shall restrain the medical marijuana market growth. China has the significant opportunities for the medical marijuana market; this is majorly due to China is primarily involved in the research and also it has heavy production of marijuana. Moreover, key players such as Hanma Investment Group received permission to extract CBD (Cannabidiol) in China. Currently this company exports 90% of its production, to the countries such as, Germany, the U.K., and the US.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/59

Pain management segment shall generate revenue of $15,133.9 million in 2026, increasing at a CAGR 28.2%. Pain management segment is broadly classified into neuropathic pain, cancer pain, and others. Rising prevalence of cancerous diseases attributed to primarily increase the necessity of pain management across the globe is anticipated to foster the global market.

Inhalation segment shall generate revenue of $25,162.8 million by the end of 2026, at a CAGR of 28.1% till 2026.This segment has enormous opportunities due to properties such as reduction in noxious emissions and quick effects. Topical segment shall generate revenue of $7,965.2 million by the end of 2026, at a CAGR of 30.2% till 2026.

Online segment will see enormous growth owing to, easy accessibility and significant changes in the legality of marijuana attributed to increasing need of E-commerce payment system in cannabis market will generate revenue of $9,558.2 million by the end of 2026, rising at a CAGR 32.3%. Dispensaries segment is expected to generate revenue of $26,647.2 million by the end of 2026, growing at a CAGR of 27.6%.

North America medical marijuana market size will cross $11,404.7 million in 2026, increasing at a CAGR 26.6%. North America marijuana market is anticipated to increase at fast rate owing to legalization of medical marijuana in Canada, in addition, extensive growth in cannabis based products for medicinal use and legalization of cannabis by the House Judiciary Committee in the US is expected boost the market in this regions.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/59

Medical Marijuana market share for Asia-Pacific region is projected to grow at a CAGR of 30.8% by generating a revenue of $8,037.6 by 2026. Asia Pacific region is projected to witness significant growth owing to the piecemeal legalization of medicinal cannabis in the nations such as Australia and Israel. Additionally, Thailand is the nation that has fully legalized medicinal marijuana with multiple clinical applications.

Some of the significant medical marijuana market players are: mCig, Emerald Health Therapeutics, ABcann Medicinals, Inc., Insys Therapeutics, Inc., Aphria, Inc., Cannabis Sativa Inc., Canopy Growth Corporation, GW Pharmaceuticals, Green Relief Inc., and Aurora Cannabis, Inc. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development. For example, to meet the demand of rising number of patients, Green Relief Inc., a licensed manufacturer of marijuana based therapeutic medicines, has officially acquired a new facility department in Canada.

Contact Us:

Corona Impact: Is Intensive Care Beds Market will Propel with its Advanced Approaches in 2020

The emergency of the COVID-19 pandemic is expected to affect the global intensive care beds market in a positive way. During this outbreak, the development of healthcare services across the globe will support the treatment of seriously unwell patients infected by the novel coronavirus. These patients require to be admitted in specialized critical care units to minimize the infection from the virus. Also, about 5% of coronavirus cases are predicted to need ICU admission for quick recovery from the virus. These factors are anticipated to increase the demand for intensive care beds and is projected to boost the market growth in the outbreak time.

In addition, major players in the market are adopting various strategies such as new technology launches and geographical expansions to upsurge their market share in the global industry. For example, in July 2020, Stryker, a leading company in medical technology, launched new ambulatory surgery center (ACS) to provide cost effective healthcare services in the pandemic period as well as in the post emergency environment. This aspect will impel the market growth in the forecast time. This report is designed to help our customers in understanding the condition of global intensive care beds market in this unprecedented period.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/361

• Our report includes:

– Technological Impact
– Social Impact
– Investment Opportunity Analysis
– Pre- & Post-COVID Market Scenario
– Infrastructure Analysis
– Supply Side & Demand Side Impact

As per a new report published by Research Dive, the global intensive care beds market is estimated to register a revenue of $2,202.9 million till 2027 and is expected to grow at a notable rate of 4.2% CAGR during the projected time from 2020 to 2027. The global market classification has been done based on product, application, end use and region. This report delivers complete information about drivers, opportunities, restraints, segmentation and significant manufacturers in the global market.

• Factors affecting the market growth

As per our analysts, growing healthcare investments and increasing hospital admissions around the world are significantly driving market growth in the projected time. Nevertheless, high costs of intensive care beds is expected to be the major restraint for the intensive care beds market growth.

• Manual beds product is expected to grow at a notable rate

By product, the global market has been divide into electrical beds, manual beds and others beds. Among these, manual beds segment is expected to witness a noteworthy growth during the review period and is expected to account for $764.4 million by 2027. Rising demand for manual beds due to its low maintenance and less expensive compared with other beds, which will drive the market growth in the forecast time.

• General ICU’s application and ambulatory surgical centers segments are projected to have significant growth

By application, the global market is classified into general ICU’s, pediatric & neonatal ICU’s and specialized ICU’s. In these, the general ICU’s application segment dominated the global market size in 2019 and is expected to reach $874.6 million till 2027. Extensive utilization of intensive care beds for general ICU’s application due to support to treat high number patients. This factor will fuel the market growth during the estimated period.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/361

By end use, the global market is classified into hospitals, ambulatory surgical centers and others. In these, ambulatory surgical centers end use segment will witness to grow at a healthy CAGR of 4.0% and is expected to register a revenue of $605.8 million in 2027. Growing number of ambulatory surgical centers due to minimize the healthcare expenditure and these centers bed capacity can be increase based on requirement, these aspects will accelerate the growth of the market in the coming years.

• Intensive care beds market, regional overview

The global intensive care beds market has been examined across several regions such as North America, Europe, Asia-Pacific and LAMEA. Among these, North America produced majority of the intensive care beds market share in 2019, which was approximately 35.0% and is projected to endure its dominance over the global industry throughout the prediction period. Along with, Asia-Pacific occupied subsequent position in the global market share in the previous years and is anticipated to reach $583.8 million till 2027. In Asia-Pacific, increasing elderly population along with rising hospital admissions in the critical care units are projected to drive the growth of the market in the forecast years.

• Top 10 Significant Players in the Global Intensive Care Beds Market Includes:

1. Invacare Corporation
2. Hillrom
3. LINET
4. Merivaara Corp.
5. Span America
6. Stryker
7. Medline Industries, Inc.
8. Getinge AB
9. Malvestio Spa
10. Stiegelmeyer GmbH & Co. KG

Contact Us:

Home

Wednesday, February 17, 2021

• Factors affecting the market growth

• Manual beds product is expected to grow at a notable rate

• General ICU’s application and ambulatory surgical centers segments are projected to have significant growth

• Intensive care beds market, regional overview

• Top 10 Significant Players in the Global Intensive Care Beds Market Includes: